What is the interpretation of a FibroScan with a CAP of 221 dB/m and an elasticity (E) value of 5.0 kPa?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

FibroScan Interpretation: CAP 221 dB/m and E 5.0 kPa

Your FibroScan results indicate no significant hepatic steatosis and no significant liver fibrosis—this represents a normal or near-normal liver assessment.

Steatosis Assessment (CAP 221 dB/m)

Your CAP value of 221 dB/m falls below the threshold for hepatic steatosis. According to EASL guidelines, CAP values above 275 dB/m are used to diagnose steatosis with over 90% sensitivity 1. More granular research data supports this interpretation:

  • CAP <240 dB/m indicates absence of significant steatosis (S0) 2
  • Your value of 221 dB/m is well below even the most sensitive cutoffs
  • Research using CAP ≥222 dB/m as a threshold for "increased CAP" demonstrates you fall just below this early indicator level 3

Clinical significance: You do not have hepatic steatosis by non-invasive criteria. This CAP value is consistent with normal liver fat content (<5% hepatocyte steatosis).

Fibrosis Assessment (LSM 5.0 kPa)

Your liver stiffness measurement of 5.0 kPa indicates no clinically significant fibrosis. Both major guidelines converge on this interpretation:

  • EASL guidelines recommend LSM by TE <8 kPa to rule out advanced fibrosis in NAFLD 1
  • The Gastroenterology Clinical Care Pathway uses 8.0 kPa as the low cutoff to exclude clinically significant fibrosis (F2-F4) with 93% sensitivity 4
  • Your value of 5.0 kPa is substantially below this threshold

Fibrosis stage interpretation:

  • F0-F1 (no to minimal fibrosis): <8.0 kPa 4
  • F≥F2 (significant fibrosis): ≥8.2 kPa 2
  • F≥F3 (advanced fibrosis): ≥9.7 kPa 2
  • F4 (cirrhosis): ≥13.6 kPa 2

Your 5.0 kPa result places you firmly in the F0-F1 category with no evidence of significant liver scarring.

Clinical Management Recommendations

For patients with LSM <8.0 kPa and normal CAP:

  • Repeat surveillance testing in 2-3 years if you have risk factors for liver disease 4
  • No need for hepatology referral at this time
  • No indication for liver biopsy
  • Continue routine metabolic health monitoring (BMI, lipids, glucose) as CAP correlates with metabolic parameters even at normal values 3

Important Caveats

These results should be interpreted in clinical context:

  • Ensure at least 1 week of alcohol abstinence before the test if you consume alcohol, as alcohol can falsely elevate LSM 1
  • Active liver inflammation (elevated ALT/AST) can artificially increase LSM independent of fibrosis
  • If you have chronic hepatitis C with sustained virologic response (SVR), these cutoffs may not apply—post-SVR patients require different interpretation 1
  • Obesity (high BMI) can affect CAP measurements, though modern XL probes have improved reliability 5

Your results indicate a healthy liver with no evidence of steatosis or fibrosis by non-invasive testing.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.